How common chemotherapy drugs in bone marrow transplantation graft prevent rejection.

Johns Hopkins and Kimmel Cancer porting people to results of a study from the Center for bone marrow transplantation, chemotherapy drug called cyclophosphamide pieces can prevent (GVHD) versus host disease may explain why. Point the immune cells to protect patients from fatal form of evasion cyclophosphamide toxicity, GVHD is experimental. In the journal Science Translational Medicine Online 11/13 published findings may pave the way for preventative treatment of recurrence of cancer or prevent GVHD and new treatment, bone marrow transplant rejection, transplant after underlying improvement.

View the original article here